Latest Content

  • COVID19 The Great Decentralized Clinical Trials Accelerator

    COVID19 The Great Decentralized Clinical Trials Accelerator

    Learn more from Roz Round, Parexel’s Vice President, Patient Innovation Center about how Decentralized Clinical Trials can help ensure patient safety and enable ongoing trial participation.

    Read More
  • ×

    Lets start a conversation...

    First Name
    Last Name
    Job Title
    Company Name
    Country
    Tell us how we can help
    Thank you! We'll be in touch soon.
    Error - something went wrong!
  • Rare disease clinical trial patient identification and recruitment

    Rare disease clinical trial patient identification and recruitment

    Read More
  • Genomics & biomarkers: Answers in the blood2:56

    Genomics & biomarkers: Answers in the blood

    Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi

    Watch Video
  • Getting real-world data into clinical research

    Getting real-world data into clinical research

    Learn more about how to address operational challenges that come with harnessing RWD.

    Read More
  • Top 10 Myths About Working with the FDA for an Oncology Drug Approval

    Top 10 Myths About Working with the FDA for an Oncology Drug Approval

    Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.

    Learn More
  • On-demand webinar: Value of real-world evidence and synthetic control arms

    On-demand webinar: Value of real-world evidence and synthetic control arms

    Learn about the benefits that real-world evidence (RWE) can bring to small & mid-size biotech companies.

    Watch Webinar
  • The future is now: Decentralized clinical trials during the pandemic and beyond

    The future is now: Decentralized clinical trials during the pandemic and beyond

    Enabling patients to participate in clinic trials from home is both important to maintain patient safety and data quality in ongoing trials and critical for many new trials as we plan for COVID-19.

    Learn More
  • Commercial and regulatory strategy considerations for biotech

    Commercial and regulatory strategy considerations for biotech

    In this blog, Parexel regulatory and strategy experts tackle the question of how we can ensure that worthy innovations in the biotech pipeline make it to patients sooner.

    Learn More
  • ×

    Tell Us About Your Biotech Goals.

    What are your top priorities for 2020?
    Thank you!
    Error - something went wrong!
  • Cell and gene therapies: for biotechs, collaboration is key to successful innovation

    Cell and gene therapies: for biotechs, collaboration is key to successful innovation

    Learn more about what to look for in the right CRO partner to overcome logistical and operational challenges in cell and gene therapy product development.

    Read More
  • Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

    Podcast: Opportunities for biotechs in precision medicine, driving value and bringing important new therapies to patients

    Parexel precision medicine experts Angela Qu and Arlene Hughes join host Alberto Grignolo to discuss how biotech companies can incorporate precision medicine into their development plans.

    Learn More
  • Endpoints That Matter2:41

    Endpoints That Matter

    Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing

    Watch Video
  • Rare disease and orphan drug designations - What you need to know

    Rare disease and orphan drug designations - What you need to know

    Collectively, rare diseases affect over 30 million Americans.  The Orphan Drug Act (ODA), which provides the statutory basis for FDA to designate a drug or biologic agent as a therapy for a...

    Learn More
  • Rescuing Product Approvals from Data Integrity Issues

    Rescuing Product Approvals from Data Integrity Issues

    The pharmaceutical industry is inundated with a plethora of communications about data integrity. Let's look at at one of these situations where applicant holders face these issues successfully.

    Learn More
  • Parexel Biotech – a patient-centric approach is in our DNA4:24

    Parexel Biotech – a patient-centric approach is in our DNA

    Hear firsthand from Monica about her personal journey as a clinical trial participant to understand the value of easing patient burden

    Watch Video
  • Parexel Biotech – designed with biotech’s unique way of working in mind2:55

    Parexel Biotech – designed with biotech’s unique way of working in mind

    James Anthony, SVP, Global Head Biotech and Graciela Rácaro, SVP, Global Head, Biotech Operations, both from Parexel, discuss how Parexel Biotech has been built to meet customer and patient needs

    Watch Video
  • Plan & engage early to manage the risks of risk management

    Plan & engage early to manage the risks of risk management

    Read More
  • Improving Drug Development & Patient Access With the Right People, Processes, and Culture

    Improving Drug Development & Patient Access With the Right People, Processes, and Culture

    Learn More
  • Learn about Parexel® Biotech

    Learn about Parexel® Biotech

    Focused on meeting customer and the patient needs with tailored, flexible solutions that speed up development and increase the likelihood of launch so that we get treatments into the hands of patients

    Read More
  • Three Keys To Mitigating Risk In Adaptive Trials

    Three Keys To Mitigating Risk In Adaptive Trials

    Read More
  • Drug development innovations that work: Adaptive trial design - BioPharma Dive

    Drug development innovations that work: Adaptive trial design - BioPharma Dive

    Read More
  • loading
    Loading More...